HIV Infection Enhances TRAIL-Induced Cell Death in Macrophage by Down-Regulating Decoy Receptor Expression and Generation of Reactive Oxygen Species

被引:70
作者
Zhu, Dan-Ming [1 ]
Shi, Juan
Liu, Shilian
Liu, Yanxin
Zheng, Dexian
机构
[1] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; MEDIATED APOPTOSIS; TUMORICIDAL ACTIVITY; MONOCLONAL-ANTIBODY; ACTIVATION; INHIBITION; PATHWAY; FAMILY; BCL-2;
D O I
10.1371/journal.pone.0018291
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) could induce apoptosis of HIV-1-infected monocyte-derived macrophage (MDM), but the molecular mechanisms are not well understood. Methodology/Principal Findings: By using an HIV-1 Env-pseudotyped virus (HIV-1 PV)-infected MDM cell model we demonstrate that HIV-1 PV infection down-regulates the expression of TRAIL decoy receptor 1 (DcR1) and 2 (DcR2), and cellular FLICE-inhibitory protein (c-FLIP), but dose not affect the expression of death receptor 4 and 5 (DR4, DR5), and Bcl-2 family members in MDM cells. Furthermore, recombinant soluble TRAIL and an agonistic anti-DR5 antibody, AD5-10, treatment stimulates reactive oxygen species (ROS) generation and JNK phosphorylation. Conclusions/Significance: HIV infection facilitates TRIAL-induced cell death in MDM by down-regulating the expression of TRAIL decoy receptors and intracellular c-FLIP. Meanwhile, the agonistic anti-DR5 antibody, AD5-10, induces apoptosis synergistically with TRAIL in HIV-1-infected cells. ROS generation and JNK phosphorylation are involved in this process. These findings potentiate clinical usage of the combination of TRAIL and AD5-10 in eradication of HIV-infected macrophage and AIDS.
引用
收藏
页数:9
相关论文
共 44 条
[41]   Proteomic analyses of monocyte-derived macrophages infected with human immunodeficiency virus type 1 primary isolates from Hispanic women with and without cognitive impairment [J].
Toro-Nieves, D. M. ;
Rodriguez, Y. ;
Plaud, M. ;
Ciborowski, P. ;
Duan, F. ;
Laspiur, J. Perez ;
Wojna, V. ;
Melendez, L. M. .
JOURNAL OF NEUROVIROLOGY, 2009, 15 (01) :36-50
[42]   HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation [J].
Tsang, Jhen ;
Chain, Benjamin M. ;
Miller, Robert F. ;
Webb, Benjamin L. J. ;
Barclay, Wendy ;
Towers, Greg J. ;
Katz, David R. ;
Noursadeghi, Mahdad .
AIDS, 2009, 23 (17) :2255-2263
[43]  
van Noesel MM, 2002, CANCER RES, V62, P2157
[44]   Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy [J].
Wei, XP ;
Decker, JM ;
Liu, HM ;
Zhang, Z ;
Arani, RB ;
Kilby, JM ;
Saag, MS ;
Wu, XY ;
Shaw, GM ;
Kappes, JC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) :1896-1905